Comment on Toshiba device tests cancer types from a drop of bloodparentComments−anon9466yReliable quantitative tests, what Theranos was promising, are significantly more difficult than screening/classification tests.
Comments
Reliable quantitative tests, what Theranos was promising, are significantly more difficult than screening/classification tests.